Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX). But which of these two ...
Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published ...
In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other Renaissance Technologies portfolio's top stock picks. The American ...
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price target upped by Royal Bank of Canada from $407.00 to $408.00 in a research note issued to investors on Thursday,Benzinga reports.
VRTX stock opened at $462.58 on Tuesday. The firm has a fifty day moving average price of $435.70 and a 200 day moving average price of $461.79. Vertex Pharmaceuticals has a fifty-two week low of ...
Vertex Pharmaceuticals VRTX has outperformed the market over the past 15 years by 5.86% on an annualized basis producing an average annual return of 17.7%. Currently, Vertex Pharmaceuticals has a ...
The Dell Latitude 5540 is one of the best laptops made for business-related work, mostly due to the fact that it comes not only with a card reader but also a fingerprint reader, making it perfect ...
In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other Renaissance Technologies portfolio's top stock picks. The American quant ...
If you’re a college student searching for a new laptop, monitor or desktop PC, then you’ll want to know how to get a Dell student discount in order to save even more money. Dell offers some of ...
As one of the most versatile laptops on the market, Dell's XPS 16 (2024) is also one of the best-designed. Its zero-lattice keyboard and brilliant 4K OLED display make for a striking first ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...